Ketamine/naltrexoneLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1948卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35808-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：251 / 251

相关论文

共 50 条

[41] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1932 (1) : 418 - 418
[42] RituximabLack of efficacy in off-label use: case report
Reactions Weekly, 2023, 1946 (1) : 492 - 492
[43] OsimertinibLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1949 (1) : 349 - 349
[44] Dexamethasone/favipiravirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1939 (1) : 173 - 173
[45] NivolumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 417 - 417
[46] FavipiravirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 175 - 175
[47] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1942 (1) : 196 - 196
[48] Fasudil/vasodilatorsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1871 (1) : 171 - 171
[49] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 44 - 44
[50] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2044 (1) : 221 - 221

← 1 2 3 4 5 →